 "Eucare Pharma's packing section")
French international life sciences group Urgo has taken an equity stake in Eucare Pharmaceuticals, an Indian family owned company based in Chennai, to establish a strategic partnership in burns, advanced wound care, surgical hemostasis and dental regeneration concepts. An MoU to this effective was signed by two companies last week.
S Sridharan, managing director of Eucare Pharmaceuticals, said, “The fast growing medical needs and healthcare system mutation is now allowing the rise for premium treatment access. With the knowledge and experience accumulated in India since our creation 20 years ago, we will lead the way to provide better care to our compatriots. We will now benefit from Urgo’s global network in serving newer international markets. The partnership will enable us to access Urgo Group’s global expertise in the areas of clinical research, manufacturing, regulatory and marketing.”
As a global leader in the advanced would care (AWC) market, Urgo constantly looks for newer markets to strengthen its market position. Like in other Asian countries, India faces many healthcare challenges and the Indian population is not spared by the chronic or acute wound burden, offering significant potential for AWC concepts. With a rising number of diabetic patients, diabetic foot ulcer is already accountable for more than 25 million wounds to be treated every year in the country.
Also Read
For over two decades, Eucare has pioneered in the area of acellular collagen technologies and drug delivery systems for burns, advanced wound management, surgical haemostasis and dental regeneration. Eucare has an established brand equity nationwide and built proprietary key account management targeting key hospital markets (corporate, public and military) with a strong distribution network. Eucare will benefit from world-expert in advanced wound care Urgo Group’s global network and expertise in innovation and pathology focused therapeutic offer.
By creating treatment tailored to each wound type, increasing education and awareness, Eucare and Urgo aim at becoming the caring partner to all major hospitals across the country.
“We are excited to set foot in India with the support and experience of our new partner. Eucare is a partner with strong market presence, manufacturing, regulatory and R&D capabilities. Urgo will now be able to provide its internationally recognised and scientifically proven TLC based wound dressing concepts to all Indian Patients,” said Pierre Moustial, general director, Urgo Group.
